Search - tctmd.com

Displaying 141 - 160 of 215

Sort: Relevancy | Date

News Daily News

Residuos Embólicos Capturados por Filtros en ¾ partes de los Pacientes TAVR

Yael L. Maxwell

May 17, 2013

News Daily News

Embolic Debris Captured by Filters in Three-Quarters of TAVR Patients

Yael L. Maxwell

May 17, 2013

Presentation Fellows 2013

Thrombectomy and Embolic Protection Systems

Presenter: Manish Parikh

April 16, 2013

News Daily News

Silent Lesions Common after CAS, but Do Not Impact Hard Events

April 05, 2013

News Daily News

Las Lesiones Silenciosas son Frecuentes tras la CAS pero No Influyen en los Episodios Objetivos

April 05, 2013

Presentation TCT 2013

Renal Angioplasty And Stenting. Limitations. Role Of Embolic Protection Devices

Presenter: Isabelle Henry, Amira BENJELLOUN, Michel Henry

January 31, 2013

Presentation TCT 2013

Release of Bioactive Lipids During Percutaneous Coronary, and Peripheral Arterial Interventions in Humans: Lipidomic analysis of Distal Embolic Protection Devices.

Presenter: Amir Ravandi, Gregor Leibundgut, Patrick Hu, Anand Prasad, Brian Kolski, Bahram Khadivi, Mitul Patel, Ehtisham Mahmud, Yury Miller, Edward Dennis, Joseph Witztum, Sotirios Tsimikas

January 31, 2013

News Daily News

Registry: Contralateral Occlusion Poses No Risk for Elective CAS

Caitlin E. Cox

January 24, 2013

News Daily News

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

L.A. McKeown

January 16, 2013

News Daily News

European Registries Show Solid Gains in TAVR Outcomes

Caitlin E. Cox

January 13, 2013

News Daily News

Un Estudio Explora los Predictores y Consecuencias de los ACV tras una TAVR

Caitlin E. Cox

November 18, 2012

News Daily News

Study Explores Predictors, Consequences of Stroke After TAVR

Caitlin E. Cox

November 18, 2012

Presentation TCT 2012

Cerebral Embolic Protection during TAVR: Metrics for Evaluating Safety and Efficacy

Presenter: Martyn Thomas

October 25, 2012

Presentation TCT 2012

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Presenter: Samir Kapadia

October 24, 2012

News Industry News

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

October 24, 2012

News Conference News TCT 2012

Mesh-Covered Stent Shines in MASTER Trial

October 24, 2012

Presentation TCT 2012

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

Presenter: Klaudija Bijuklic

October 23, 2012

News Conference News TCT 2012

Successful Device Innovation Focuses on Clinical Needs, Multidisciplinary Approach

October 23, 2012

News Conference News TCT 2012

Review of TAVR Use Offers Significant Advances, Positive Outcomes

October 22, 2012

News Conference News TCT 2012

Israeli Innovations Include ‘Cath Lab of the Future,’ Stent and Digital Developments

October 22, 2012

Advertisement

Residuos Embólicos Capturados por Filtros en ¾ partes de los Pacientes TAVR

Embolic Debris Captured by Filters in Three-Quarters of TAVR Patients

Thrombectomy and Embolic Protection Systems

Silent Lesions Common after CAS, but Do Not Impact Hard Events

Las Lesiones Silenciosas son Frecuentes tras la CAS pero No Influyen en los Episodios Objetivos

Renal Angioplasty And Stenting. Limitations. Role Of Embolic Protection Devices

Release of Bioactive Lipids During Percutaneous Coronary, and Peripheral Arterial Interventions in Humans: Lipidomic analysis of Distal Embolic Protection Devices.

Registry: Contralateral Occlusion Poses No Risk for Elective CAS

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

European Registries Show Solid Gains in TAVR Outcomes

Un Estudio Explora los Predictores y Consecuencias de los ACV tras una TAVR

Study Explores Predictors, Consequences of Stroke After TAVR

Cerebral Embolic Protection during TAVR: Metrics for Evaluating Safety and Efficacy

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

Mesh-Covered Stent Shines in MASTER Trial

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

Successful Device Innovation Focuses on Clinical Needs, Multidisciplinary Approach

Review of TAVR Use Offers Significant Advances, Positive Outcomes

Israeli Innovations Include ‘Cath Lab of the Future,’ Stent and Digital Developments

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content